Last $28.87 USD
Change Today -1.23 / -4.09%
Volume 501.6K
EBS On Other Exchanges
As of 6:40 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert G. Kramer Sr.

Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Corporate Services Division and Treasurer, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Robert G. Kramer, Sr. has been Executive Vice President of Corporate Services Division at Emergent BioSolutions, Inc. since September 2012 and has been its Chief Financial Officer since December 2012 and is responsible for its legal affairs, strategic investments, human capital, management services and sales & marketing. Mr. Kramer serves as the Principal Accounting Officer and Treasurer at Emergent BioSolutions, Inc. He serves as the President and Chief Operating ...

Read Full Background

Corporate Headquarters*

2273 Research Boulevard
Rockville, Maryland 20850

United States

Phone: 301-795-1800
Fax: 301-795-1899

Board Members Memberships*

President, Chief Operating Officer and Director
Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Corporate Services Division and Treasurer
Director of Ronald McDonald House of Mid-Michigan


Clemson University
Western Kentucky University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$694,200

Stock Options*

Restricted Stock Awards$57,800
Exercisable Options7,688
Exercisable Options Value$65,963
Unexercisable Options23,253
Unexercisable Options Value$197,462
Total Value of Options$263,425
Total Number of Options30,941

Total Compensation*

Total Annual Cash Compensation$694,200
Total Short Term Compensation$694,200
Other Long Term Compensation$57,800
Total Calculated Compensation$800,747
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $28.87 USD -1.23


Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at